̽��ֱ�� of Cambridge - Department of Physiology Development and Neuroscience

Hundreds of A-level students see grades rise and secure places at top universities following Cambridge's STEM SMART initiative

sb726 — Mon, 07 Apr 2025 07:30:17 +0000

UCAS evaluation shows the most engaged sixth formers saw their results jump by a grade on average, were up to four times as successful in achieving an A*, and around twice as successful in securing an Oxbridge place.

̽��ֱ��Cambridge Awards 2024 for Research Impact and Engagement

zs332 — Mon, 03 Feb 2025 10:27:01 +0000

Meet the winner of the Cambridge Awards 2024 for Research Impact and Engagement and learn more about their projects.

Cambridge scientists elected as Members of the European Molecular Biology Organisation

jg533 — Tue, 09 Jul 2024 12:00:56 +0000

Five Cambridge researchers join the community of over 2,100 leading life scientists today as the European Molecular Biology Organisation (EMBO) announces its newest Members in its 60th anniversary year.

Cambridge ReseARch Trail

zs332 — Thu, 14 Mar 2024 16:34:06 +0000

A new augmented reality trail, launched as part of the Cambridge Festival, is showcasing the world leading research of the ̽��ֱ�� of Cambridge in a new light.

Journeys of discovery: Christine Holt on how our brains wire-up

Anonymous — Wed, 18 Oct 2023 08:22:01 +0000

Christine Holt knew she’d solved one of the key puzzles of how brains wire-up, but convincing others was no easy matter.

Combined steroid and statin treatment could reduce ‘accelerated ageing’ in preterm babies, study in rats suggests

cg605 — Thu, 02 Feb 2023 09:20:05 +0000

Cambridge scientists gave new-born rats, which are naturally born prematurely, combined glucocorticoid steroids and statin therapy. ̽��ֱ��results, published today in Hypertension, show that the combined treatment led to the elimination of negative effects of steroids on the cardiovascular system while retaining their positive effects on the developing respiratory system.

Preterm birth (before 37 weeks) is one of the greatest killers in perinatal medicine today. One in ten babies is born preterm in high-income countries; this can increase to almost 40% in low- and middle-income countries.

Preterm babies are extremely vulnerable because they miss out on a crucial final developmental stage in which the hormone cortisol is produced and released exponentially into the unborn baby’s blood. Cortisol is vital to the maturation of organs and systems that are needed to keep the baby alive once born.

For example, in the lungs, cortisol ensures that they become more elastic. This allows the lungs to expand so the baby can take its first breath. Without cortisol the new-born lungs would be too stiff, which leads to respiratory distress syndrome (RDS) and could be fatal.

̽��ֱ��established clinical treatment for any pregnancy threatened with preterm birth is glucocorticoid therapy, given via the mother before the baby is born and/or directly to the baby after birth. These synthetic steroids mimic the natural cortisol by speeding up the development of organs – including the lungs – which means the preterm baby is much more likely to survive.

Lead author Professor Dino Giussani from the Department of Physiology, Development and Neuroscience at the ̽��ֱ�� of Cambridge said: “Glucocorticoids are a clear lifesaver, but the problem with steroids is that they speed up the maturation of all organs. For the baby’s lungs this is beneficial, but for the heart and circulation system it can be damaging – it resembles accelerated ageing.”

A previous clinical study by Professor Paul Leeson’s laboratory at Oxford ̽��ֱ�� found that people who had been exposed to glucocorticoid therapy as unborn babies, via their mothers, showed measures of cardiovascular health typical of people a decade older.

Cambridge researcher Dr Andrew Kane, involved in the rat study, thought that this accelerated ageing could result from steroids causing oxidative stress Steroids lead to an imbalance of molecules known as free radicals, which result in a reduction in nitric oxide. Nitric oxide is very beneficial to the cardiovascular system – it increases blood flow and has anti-oxidant and anti-inflammatory properties.

To test if a lack of nitric oxide could be the origin of the adverse negative cardiovascular side-effects associated with glucocorticoid therapy, the researchers combined the steroid treatment with statins, which are widely used to lower cholesterol and are known to increase nitric oxide.

Researchers gave the synthetic steroid, dexamethasone, combined with the statin, pravastatin, to rat pups. There were three other groups – one receiving dexamethasone alone, one receiving pravastatin alone and a control group that received saline. Measures of respiratory and cardiovascular function were then taken when the rats had grown to ‘childhood’.

̽��ֱ��Cambridge scientists found that steroids produced adverse effects on heart and blood vessels, and molecular indices associated with cardiovascular problems. But if statins were given at the same time, the rats were protected from these effects. Crucially, the statins did not affect any of the beneficial effects of steroids on the respiratory system.

“Our discovery suggests that combined glucocorticoid and statin therapy may be safer than glucocorticoids alone for the treatment of preterm babies,” said Professor Giussani.

“We’re not saying to stop using glucocorticoids, as they are clearly a life-saving treatment. We’re saying that to improve this therapy – to fine tune it – we could combine it with statins. This gives us the best of both worlds – we can maintain the benefits of steroids on the developing lungs, but ‘weed out’ their adverse side-effects on the developing heart and circulation, thereby making therapy much safer for the treatment of preterm birth.”

̽��ֱ��team plan to replicate the experiment in sheep, which have a similar physiology to humans, before conducting human clinical trials.

̽��ֱ��research was funded by the British Heart Foundation and the Biotechnology and Biological Sciences Research Council (BBSRC). Dr Andrew Kane was supported by the Frank Edward Elmore Fund and the James Baird Fund.

Giussani, DA et al. Combined statin and glucocorticoid therapy for the safer treatment of preterm birth. Hypertension; 1 Feb 2023; DOI: 10.1161/HYPERTENSIONAHA.122.19647

Potentially life-saving steroids commonly given to preterm babies also increase the risk of long-term cardiovascular problems, but a new study in rats has found that if given in conjunction with statins, their positive effects remain while the potential negative side-effects are ‘weeded out’.

We’re not saying to stop using glucocorticoids, as they are clearly a life-saving treatment. We’re saying that to improve this therapy – to fine tune it – we could combine it with statins.

IvanJekic / E+ via Getty Images

Mother is holding a tiny hand of her preterm baby that is in the NICU.

̽��ֱ��text in this work is licensed under a Creative Commons Attribution 4.0 International License. Images, including our videos, are Copyright © ̽��ֱ�� of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – as here, on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

Yes

Cambridge researchers awarded European Research Council Consolidator Grants

cg605 — Tue, 31 Jan 2023 16:00:25 +0000

̽��ֱ��ERC is the premier European funding organisation for excellent frontier research. This year it has awarded €657m in grants to 321 researchers across Europe.

Consolidator grants are given to excellent scientists, who have 7 to 12 years’ experience after their PhDs, to pursue their most promising ideas.

“ERC Consolidator grants support researchers at a crucial time of their careers, strengthening their independence, reinforcing their teams and helping them establish themselves as leaders in their fields,” said President of the European Research Council Professor Maria Leptin. “And this backing above all gives them a chance to pursue their scientific dreams.”

Cambridge awardees:

Dr Eloy de Lera Acedo, STFC Ernest Rutherford Fellow at Cavendish Astrophysics and the Kavli Institute for Cosmology of the Department of Physics, has been awarded a grant for REACH_21: Probing the Cosmic Dawn and Epoch of Re-ionization with the REACH experiment.

De Lera Acedo said: “REACH_21 aims to unveil the mysteries of the infant universe. We want to answer the question: how did the cosmos, that evolved from the Big Bang, become the complex and luminous realm of celestial objects we can see from planet Earth today?

“This unknown missing piece in the puzzle of the history of the universe is now closer to being understood thanks to a new experimental approach that attempts to observe extremely faint radio signals emitted nearly 13.5 billion years ago by the most abundant element at that time: Neutral Hydrogen.”

“This is amazing news for the REACH collaboration. We have been designing our experiment for over five years and are currently awaiting the start of scientific observations in South Africa. ̽��ֱ��ERC grant is going to allow me to use the REACH telescope, analyse its data, and hopefully access a whole new world of information about the early evolution of the cosmos.”

Dr Daniel Hodson, of the Department of Haematology, has been awarded a grant for Unwind-Lymphoma: RNA helicases; switched paralogue dependency as an exploitable vulnerability in aggressive B cell lymphoma.

Hodson said: “This ERC-funded project, Unwind Lymphoma, will explore sex-specific, cancer cell addiction to the DDX3 family of RNA helicases, proteins that unwind secondary structure in mRNA.

“We will develop recent findings from our lab showing that whilst most male Burkitt lymphoma cells have deleted the X-chromosome gene DDX3X, they instead become uniquely addicted to the Y-chromosome paralogue DDX3Y, a related protein that is silenced in most normal cells. By unravelling the molecular basis of this ‘switched paralogue dependency’ we will expose a potential therapeutic Achilles Heel in this devastating form of blood cancer.

“I am thrilled to receive this award, which I hope will take me one step closer to a tenured position in Cambridge or beyond.”

Sohini Kar-Narayan, Professor of Device and Energy Materials of the Department of Materials Science and Metallurgy, has been awarded a grant for BIOTRONICA: Bio-Electronic Integrated Devices for Healthcare Applications.

Kar-Narayan said: “My research focuses on the development and characterisation of novel functional polymers and nanocomposites, and their application in functional devices using microscale additive manufacturing methods. It covers novel energy harvesting nanomaterials to microfluidic biosensors, to materials and devices for next-generation flexible and wearable electronics.

“I am absolutely delighted to have been awarded a Consolidator Grant to develop new tools for remote health monitoring and personalised medicine. These include novel non-invasive ‘point-of-care’ biosensors, which could potentially be self-powered through energy harvested from the body, thus enabling a step change in health monitoring and patient care.”

Dr Elisa Laurenti, ̽��ֱ�� Associate Professor in Stem Cell Medicine and Wellcome Royal Society Sir Henry Dale Fellow of the Wellcome Medical Research Council Cambridge Stem Cell Institute and Department of Haematology, has been awarded a grant for HEXAGEN: Harnessing haematopoietic stem cell EX vivo Adaptation for GENe therapy.

Laurenti said: “Blood stem cell-based gene therapy has the potential to cure an expanding range of debilitating genetic diseases. HEXAGEN seeks to further improve gene therapies and their outcomes by overcoming the loss of stem cell function observed in current clinical protocols. Using cutting edge single cell technologies, we aim to identify how blood stem cells adapt to the invitro environment, dissect how this negatively impacts their function, and design new strategies to improve gene therapy.

“This award gives my team the unique opportunity to be ambitious and complete a full circle from basic stem cell biology to improving gene therapy for patients with many diseases. I am very excited, because unlocking blood stem cell behaviour outside our bodies will also drive many other clinical applications.”

Dr Naomi McGovern, of the Department of Pathology and the Centre for Trophoblast Research, has been awarded a grant for PMDR: Placental macrophages: Their development and role in the placenta.

McGovern said: “My team’s research focus is human placental macrophage biology. We are interested in determining the role of these cells in mediating healthy placental function and in protecting the placenta from infection. By developing our understanding of these cells, we will be able to provide new insight into pregnancy disorders.

“I am delighted that our proposal was selected for an ERC Consolidator Award. It is an acknowledgement of the exciting research my team carries out. ̽��ֱ��hard work of my team and the additional expertise provided by our supportive collaborators all helped to form the basis for this proposal. ̽��ֱ��award will provide my group with the time and resources to undertake high-risk research to inform on placental biology. It is now up to us to deliver on this generous investment.”

Professor Robert Phipps, of the Yusuf Hamied Department of Chemistry, has been awarded a grant for IonPairEnantRadical: Transforming Enantioselective Radical Chemistry using Ion-Pairing Catalysis.

Phipps said: “Chemical reactions that are driven by radical mechanisms are rapidly growing in importance, but it is an ongoing challenging to control enantioseletivity in those that form stereocentres. This grant will fund an ambitious program which will apply innovative and unexplored ion-pairing strategies to control enantioselectivity in a variety of important radical chemistries for which there are no or limited existing methods for imposing enantiocontrol.

“I am extremely grateful that my proposal was selected for funding in this very competitive call. I am excited about the chemistry that my group will be able to explore over the coming five years with this fantastic opportunity!”

Akshay Rao, Professor of Physics of the Cavendish Laboratory in the Department of Physics, has been awarded a grant for SPICE: Spin-Exchange and Energy Transfer at Hybrid Molecular/Lanthanide Nanoparticle Interfaces to Control Triplet Excitons.

Rao said: “Our project, SPICE, will explore the physics and chemistry of a new class of hybrid materials, organic molecules connected to lanthanide doped nanoparticles.

“Although we are still at an early stage of research, if we succeed it may create transformative applications in areas ranging from optoelectronics, data communication, photocatalysis, optogenetics and 3D bio-printing. Over the long term this kind of blue-sky science is what drives technological innovation helping to drive improved productivity in industry, but also directly tacking major societal challenges such as climate change and health.

“We are delighted that our project has received the support of the European Research Council. This is a great opportunity for us to pursue high-risk high-gain blue-sky science and push the limits of our understanding of these materials and take them towards application. ̽��ֱ��award also serves as recognition of the excellent science done by our PhD students and postdoctoral researchers, who’s tireless efforts to push the scientific frontier have made possible the breakthroughs that have brought us here.”

Dr Milka Sarris, Assistant Professor of the Department of Physiology, Development and Neuroscience, was awarded a grant for LongWayFromFlam: ̽��ֱ��uncharted journeys of inflammatory cells and their functional implications.

Sarris said: “My group studies how cells of the immune system move in the body to generate and resolve inflammatory responses. To study these processes, we use state of the art microscopy techniques and genetic approaches in zebrafish, a small vertebrate model organism.

“I am absolutely thrilled to have won this award at a key stage of my career and to be able to pursue an ambitious new line of fundamental research. It was a long process and I remain very grateful to my university colleagues, the peer reviewers and the evaluation committee for their feedback.”

Eight researchers from the ̽��ֱ�� of Cambridge have won European Research Council (ERC) Consolidator Grants

Photos provided by winners

From clockwise: Eloy de Lera Acedo, Daniel Hodson, Sohini Kar-Narayan, Elisa Laurenti, Naomi McGovern, Robert Phipps, Akshay Rao and Milka Sarris.

Yes

Mind Over Chatter: ̽��ֱ��future of reproduction

ns480 — Thu, 27 May 2021 12:41:58 +0000

Season 2, episode 6

Our reproductive capabilities are changing in exciting ways, altering our fundamental understanding of fertility, reproduction, and even parenthood.

In this episode of Mind Over Chatter, we ask our guests what the consequences of novel reproductive technologies are likely to be, and how they will impact the future of human reproduction.

Subscribe to Mind Over Chatter

We cover topics ranging from egg-freezing, so-called ‘three-parent-babies, and the importance of studying the embryonic development of primates.

Historical demographer, Dr Alice Reid, who researches fertility, mortality and health in the late nineteenth and early twentieth centuries, tells us how reproduction has changed over the last 200 years and how it has been influenced by improvements in gender equality, as well as discussing the likely demographic impact of assisted reproduction.

Dr Lucy Van de Wiel, whose research focuses on the social and cultural analysis of assisted reproductive technologies such as egg freezing, introduces the important ways in which reproductive technologies must be considered in the context of wide social and political issues.

Finally, Dr Thorsten Boroviak shares his cutting-edge research on developing new reproductive technologies – the ability to generate your own egg or sperm from any cell of your body – and the importance of studying the embryonic development of primates.

Key points:

[2:10]- change of human reproduction over the last 200 years

[5:45]- egg freezing and changing meaning of what it means to be ‘fertile’

[12:05]- higher levels of gender equity can produce higher levels of fertility

[23:19]- generating eggs and sperms from any human cell

[24:02]- can a man produce an egg?

[40:37]- when should one freeze their eggs?

[64:54]- reproductive justice and reproductive equity. Ensuring reproductive autonomy while ensuring non-exploitation

[65:59]- Final question: what is the most exciting thing that will happen to humankind in the future?

Mind Over Chatter: ̽��ֱ��Cambridge ̽��ֱ�� Podcast